ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 687,38
0,30%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) Actualités

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DateHeureSourceTitreSymboleSociété
13/01/201118h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACENASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/01/201121h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support AgreemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/01/201123h26Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/01/201102h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKETNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/12/201020h30PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note IndentureNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/12/201018h18PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. LitigationNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/11/201018h30PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGICNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/11/201020h15PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LPNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/11/201023h08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/201011h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/10/201002h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial InformationNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/10/201002h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated NotehoNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/10/201001h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCASTNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/10/201014h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against tNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/10/201014h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/09/201017h30PR Newswire (US)ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-CNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/09/201020h30PR Newswire (US)ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIENASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/09/201020h45PR Newswire (US)ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/09/201020h45PR Newswire (US)ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONSNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/08/201022h40Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/08/201022h31Dow Jones NewsUPDATE:FDA Warns About Long-Term Problems With Blood-Clot DeviceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/08/201021h22Dow Jones NewsFDA Warns About Long-Term Problems With Blood-Clot DeviceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/07/201014h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
28/07/201022h23PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patiNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
08/07/201019h00PR Newswire (US)Angiotech Pharmaceuticals announces notice of failure to satisfy a continued listing rule with The Nasdaq Stock Market.NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/06/201019h00PR Newswire (US)Angiotech Pharmaceuticals Announces Conference Call and WebcastNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/06/201012h03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
11/06/201019h00PR Newswire (US)Angiotech's licensee, Cook Medical, files PMA submission for FDA approval of Zilver(R) PTX(R) Drug-Eluting Stent platformNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
11/06/201000h30PR Newswire (US)Angiotech Pharmaceuticals announces acceptance of 2010 medical design excellence award for Quill(TM) SRSNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/06/201020h00PR Newswire (US)Angiotech Pharmaceuticals announces European launch and first implants of Boston Scientific Corporation's platinum chromium TAXUNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Dernières Valeurs Consultées

UPBT
BSVKRW
Bitcoin SV
BIT
I10074
IT0005590762 20240902 31
EU
HTR
HSBC Turkey
BIT
P22GP2
NLBNPIT22GP2 20240920 36
BIT
P1TRE7
BNP Paribas Issuance
BIT
P21HY4
NLBNPIT21HY4 20240620 16...
LSE
WINC
Ish Wld Hi Dis
LSE
19VY
Barclays 43
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés